Cancer Therapy News and Research

RSS

New drug data release set to power genetic research into cancer treatment

This week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and exploration which will power genetic research into cancer treatment worldwide.

26 Jul 2019

Study proposes new way of concentrating radiotherapy dose in tumors

A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde.

26 Jul 2019

Women who inherit BRCA mutations have high risk of developing cancer

Women who inherit harmful mutations in the BRCA1 or BRCA2 gene are at high risk of developing breast and ovarian cancer.

24 Jul 2019

Common feature that makes cancer cells appear bloated could be their potential weak spot

In a study using yeast cells and data from cancer cell lines, Johns Hopkins University scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes, the structures that carry genetic material.

23 Jul 2019

Key metabolic changes found in patients with chemotherapy-related heart toxicity

More and more patients are being treated successfully for cancer. However, some cancer treatments that are very effective for breast cancer – medications like anthracyclines and trastuzumab – can cause heart dysfunction and lead to heart failure.

19 Jul 2019

New research links “broken heart syndrome” to cancer

Researchers have discovered a new link between broken-heart syndrome, or takotsubo syndrome, and the second leading cause of death in the world: cancer.

18 Jul 2019

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

New method spots rare immune cells reactive against cancer

Researchers from the Garvan Institute of Medical Research have developed a new method to spot rare immune cells that are reactive against cancer cells, from within a patient's own immune system.

16 Jul 2019

UMass Amherst scientist receives $792,000 grant to advance cancer immunotherapy research

Biomedical engineer Ashish Kulkarni, assistant professor of chemical engineering at the University of Massachusetts Amherst, has been awarded a four-year, $792,000 grant from the American Cancer Society to advance his interdisciplinary lab's promising cancer immunotherapy research.

16 Jul 2019

Combining breast and gynecologic surgery not such a good idea

A new study from the University of Colorado Cancer Center finds that it is best if women who have to have both preventive gynecologic and breast surgeries have them done separately. The same dictum applies to breast reconstructive procedures following a mastectomy.

16 Jul 2019

New protein target for deadly ovarian cancer

A new study shows that targeting a specific protein found within quickly spreading high-grade serous carcinomas (HGSC) of the ovary could help contain these cancers. HGSC is the most common and deadly form of epithelial ovarian cancer, which is itself the deadliest cancer of the female reproductive tract.

14 Jul 2019

Reprogramming cells to control HIV infection

Cells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 15 years with the aim of elucidating their specific features.

14 Jul 2019

Study: Nearly a quarter of low-risk thyroid cancer patients receive more treatment than necessary

Nearly a million Americans live with thyroid cancer and doctors will diagnose more than 50,000 new cases this year. Fortunately, the survival rate for this kind of cancer is one of the best. Five years after diagnosis, more than 98 percent of patients are survivors.

11 Jul 2019

Comprehensive cell atlas of the human liver

The liver is one of the largest and most versatile organs of the human body. It turns sugars, proteins, and fats from our food into substances useful for the body and releases them to the cells.

11 Jul 2019

Medicare going in ‘right direction’ on opioid epidemic

Prescriptions for two drugs used to treat opioid addiction increased significantly from 2016 to 2018 for people on Medicare, according to a federal report out Wednesday.

10 Jul 2019

Cancer killing capability of lesser-known immune cells identified

Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.

10 Jul 2019

Special blood test may predict relapse risk for breast cancer patients

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

9 Jul 2019

Thioredoxin antioxidant could soon be used to improve cancer treatment

Researchers from Medical University of South Carolina (MUSC) have discovered the use of thioredoxin – a naturally occurring antioxidant to modulate T cells of the immune system. This may be a big step towards improving currently used immune therapies such as adoptive T-cell therapy (ACT) and hematopoietic stem cell transplantation (HSCT).

8 Jul 2019

Common cold virus strain could be a breakthrough in bladder cancer treatment

Scientists in the UK have found a new way to treat bladder cancer, using a strain of one of the viruses that cause the common cold. The virus is called Coxsackie virus CVA21, and it was found to be oncolytic, or tumor-destroying.

8 Jul 2019